Kamada logo

Kamada share price today

(KMDA)

Kamada share price is $5.9 & ₹501.36 as on 21 Dec 2024, 2.30 'hrs' IST

$5.9

0.05

(0.85%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Kamada share price in Dollar and Rupees. Guide to invest in Kamada from India. Also see the sentimental analysis on Indian investors investing in Kamada. Get details on the Indian mutual funds that are investing in Kamada. Get Analyst recommendations and forecasts along with all the Kamada's financials.

Kamada share price movements

  • Today's Low: $5.83
    Today's High: $5.99

    Day's Volatility :2.55%

  • 52 Weeks Low: $4.74
    52 Weeks High: $6.53

    52 Weeks Volatility :27.4%

Kamada Returns

PeriodKamada LtdSector (Health Care)Index (Russel 2000)
3 Months
11.11%
-11.1%
0.0%
6 Months
18.71%
-6.0%
0.0%
1 Year
-3.05%
2.7%
0.0%
3 Years
-9.92%
0.6%
-19.7%

Kamada Key Statistics

in dollars & INR

Previous Close
$5.85
Open
$5.94
Today's High
$5.985
Today's Low
$5.8324
Market Capitalization
$350.6M
Today's Volume
$17.7K
52 Week High
$6.5291
52 Week Low
$4.74
Revenue TTM
$154.6M
EBITDA
$28.4M
Earnings Per Share (EPS)
$0.27
PE Ratio
21.67
Profit Margin
9.75%
Quarterly Earnings Growth YOY
1.0%
Return On Equity TTM
7.05%

How to invest in Kamada from India?

It is very easy for Indian residents to invest directly in Kamada from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kamada stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kamada or KMDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kamada or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kamada shares which would translate to 0.144 fractional shares of Kamada as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Kamada, in just a few clicks!

Returns in Kamada for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kamada investment value today

Current value as on today

₹1,05,316

Returns

₹5,316

(+5.32%)

Returns from Kamada Stock

₹3,120 (false-3.12%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Kamada

17%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Kamada on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 17% more investors are searching Kamada in the last 30 days versus the previous period.

Global Institutional Holdings in Kamada

    Analyst Recommendation on Kamada

    Buy

      85%Buy

      14%Hold

      0%Sell

    Based on 7 Wall street analysts offering stock ratings for Kamada(by analysts ranked 0 to 5 stars)

    Based on 7 analyst
    • Current
    • 1M Ago
    • 3M Ago
    Buy
    6
    6
    6
    Hold
    1
    1
    1
    Sell
    0
    0
    0

    Analyst Forecast on Kamada

    What analysts predicted

    Upside of 148.59%

    Current:

    $5.90

    Target:

    $14.67

    Insights on Kamada

    • Price Movement

      In the last 7 days, KMDA stock has moved up by 0.5%
    • Decreasing Revenue

      Revenue is down for the last 2 quarters, 41.87M → 41.74M (in $), with an average decrease of 0.3% per quarter
    • Decreasing Net Profit

      Netprofit is down for the last 2 quarters, 4.42M → 3.86M (in $), with an average decrease of 12.7% per quarter
    • KMDA vs HLN (1 yr)

      In the last 1 year, Haleon Plc Spon Ads has given 18.3% return, outperforming this stock by 19.3%
    • Price to Sales

      ForKMDA every $1 of sales, investors are willing to pay $2.1, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

    Kamada Financials in INR & Dollars

    FY18Y/Y Change
    Revenue
    $114.5M
    ↑ 11.32%
    Net Income
    $22.3M
    ↑ 223.08%
    Net Profit Margin
    19.48%
    ↑ 12.77%
    FY19Y/Y Change
    Revenue
    $127.2M
    ↑ 11.11%
    Net Income
    $22.3M
    ↓ 0.2%
    Net Profit Margin
    17.49%
    ↓ 1.99%
    FY20Y/Y Change
    Revenue
    $133.2M
    ↑ 4.76%
    Net Income
    $17.1M
    ↓ 22.97%
    Net Profit Margin
    12.86%
    ↓ 4.63%
    FY21Y/Y Change
    Revenue
    $103.6M
    ↓ 22.22%
    Net Income
    $-2.2M
    ↓ 113.01%
    Net Profit Margin
    -2.15%
    ↓ 15.01%
    FY22Y/Y Change
    Revenue
    $129.3M
    ↑ 24.79%
    Net Income
    $-2.3M
    ↑ 4.08%
    Net Profit Margin
    -1.79%
    ↑ 0.36%
    FY23Y/Y Change
    Revenue
    $142.5M
    ↑ 10.19%
    Net Income
    $8.3M
    ↓ 456.92%
    Net Profit Margin
    5.81%
    ↑ 7.6%
    Q2 FY23Q/Q Change
    Revenue
    $37.4M
    ↑ 0.0%
    Net Income
    $1.8M
    ↑ 0.0%
    Net Profit Margin
    4.84%
    ↑ 0.0%
    Q3 FY23Q/Q Change
    Revenue
    $37.9M
    ↑ 1.31%
    Net Income
    $3.2M
    ↑ 77.87%
    Net Profit Margin
    8.5%
    ↑ 3.66%
    Q4 FY23Q/Q Change
    Revenue
    $37.4M
    ↓ 1.41%
    Net Income
    $2.4M
    ↓ 26.62%
    Net Profit Margin
    6.32%
    ↓ 2.18%
    Q1 FY24Q/Q Change
    Revenue
    $37.7M
    ↑ 0.9%
    Net Income
    $2.4M
    ↑ 0.0%
    Net Profit Margin
    6.27%
    ↓ 0.05%
    Q2 FY24Q/Q Change
    Revenue
    $41.9M
    ↑ 10.97%
    Net Income
    $4.4M
    ↑ 87.15%
    Net Profit Margin
    10.57%
    ↑ 4.3%
    Q3 FY24Q/Q Change
    Revenue
    $41.7M
    ↓ 0.33%
    Net Income
    $3.9M
    ↓ 12.72%
    Net Profit Margin
    9.25%
    ↓ 1.32%
    FY18Y/Y Change
    Profit
    $41.5M
    ↑ 29.24%
    FY19Y/Y Change
    Profit
    $49.7M
    ↑ 19.93%
    FY20Y/Y Change
    Profit
    $47.6M
    ↓ 4.39%
    FY21Y/Y Change
    Profit
    $30.3M
    ↓ 36.22%
    FY22Y/Y Change
    Profit
    $46.7M
    ↑ 53.99%
    FY23Y/Y Change
    Profit
    $55.5M
    ↑ 18.81%
    Q2 FY23Q/Q Change
    Profit
    $14.4M
    ↑ 0.0%
    Q3 FY23Q/Q Change
    Profit
    $14.8M
    ↑ 2.54%
    Q4 FY23Q/Q Change
    Profit
    $16.6M
    ↑ 12.15%
    Q1 FY24Q/Q Change
    Profit
    $16.8M
    ↑ 0.9%
    Q2 FY24Q/Q Change
    Profit
    $18.7M
    ↑ 11.55%
    Q3 FY24Q/Q Change
    Profit
    $17.2M
    ↓ 7.77%
    FY18Y/Y Change
    Operating Cash Flow
    $10.5M
    ↑ 171.11%
    Investing Cash Flow
    $-5.2M
    ↓ 66.84%
    Financing Cash Flow
    $-587.0K
    ↓ 103.83%
    FY19Y/Y Change
    Operating Cash Flow
    $27.6M
    ↑ 161.44%
    Investing Cash Flow
    $-564.0K
    ↓ 89.1%
    Financing Cash Flow
    $-1.5M
    ↑ 160.65%
    FY20Y/Y Change
    Operating Cash Flow
    $19.1M
    ↓ 30.71%
    Investing Cash Flow
    $-13.1M
    ↑ 2227.48%
    Financing Cash Flow
    $23.4M
    ↓ 1627.06%
    FY21Y/Y Change
    Operating Cash Flow
    $-8.8M
    ↓ 146.16%
    Investing Cash Flow
    $-61.1M
    ↑ 365.07%
    Financing Cash Flow
    $18.6M
    ↓ 20.42%
    FY22Y/Y Change
    Operating Cash Flow
    $28.6M
    ↓ 424.14%
    Investing Cash Flow
    $-3.8M
    ↓ 93.8%
    Financing Cash Flow
    $-9.3M
    ↓ 150.25%
    Q2 FY23Q/Q Change
    Operating Cash Flow
    $1.8M
    ↑ 0.0%
    Investing Cash Flow
    $-1.0M
    ↓ 2.1%
    Financing Cash Flow
    $-5.9M
    ↑ 0.0%
    Q3 FY23Q/Q Change
    Operating Cash Flow
    $921.0K
    ↓ 49.34%
    Investing Cash Flow
    $-1.7M
    ↑ 64.98%
    Financing Cash Flow
    $31.3M
    ↓ 634.5%

    Kamada Technicals Summary

    Sell

    Neutral

    Buy

    Kamada is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

    Kamada Vs Peers

    Company Name1 Month6 Month1 Year3 Years5 Years
    Kamada Ltd
    0.85%
    18.71%
    -3.05%
    -9.92%
    -13.24%
    Neurocrine Biosciences Inc.
    8.34%
    1.35%
    5.43%
    59.49%
    24.91%
    Haleon Plc Spon Ads
    1.47%
    12.15%
    18.9%
    30.77%
    30.77%
    Zoetis Inc.
    -6.72%
    -4.07%
    -15.46%
    -31.76%
    24.53%
    Viatris Inc.
    -5.51%
    19.58%
    17.56%
    -5.51%
    -23.38%
    Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
    Kamada Ltd
    21.67
    21.67
    8.75
    0.26
    0.07
    0.03
    NA
    4.25
    Neurocrine Biosciences Inc.
    35.99
    35.99
    0.32
    6.54
    0.16
    0.12
    NA
    26.87
    Haleon Plc Spon Ads
    28.53
    28.53
    1.73
    0.34
    0.07
    0.04
    0.02
    1.82
    Zoetis Inc.
    30.68
    30.68
    2.6
    5.88
    0.47
    0.15
    0.01
    11.59
    Viatris Inc.
    224.4
    NA
    0.07
    2.69
    -0.04
    0.02
    0.04
    16.58
    Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
    Kamada Ltd
    Buy
    $350.6M
    -13.24%
    21.67
    9.75%
    Neurocrine Biosciences Inc.
    Buy
    $13.7B
    24.91%
    35.99
    17.21%
    Haleon Plc Spon Ads
    Buy
    $44.1B
    30.77%
    28.53
    10.75%
    Zoetis Inc.
    Buy
    $73.8B
    24.53%
    30.68
    26.55%
    Viatris Inc.
    Hold
    $14.5B
    -23.38%
    224.4
    -5.87%

    About Kamada

    kamada ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. the company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce alpha-1 antitrypsin (aat) in a highly-purified, liquid form, as well as other plasma-derived proteins. aat is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties. the company’s flagship product is glassia®, the first and only liquid, ready-to-use, intravenous plasma-derived aat product approved by the u.s. food and drug administration. kamada markets glassia in the u.s. through a strategic partnership with baxter international. in addition to glassia, kamada has a product line of nine other pharmaceutical products that are marketed through distributor
    Organization
    Kamada
    Employees
    378
    CEO
    Mr. Amir London
    Industry
    Health Technology

    Management People of Kamada

    NameTitle
    Mr. Amir London
    Chief Executive Officer
    Mr. Chaime Orlev
    Chief Financial Officer
    Mr. Eran Nir
    Chief Operating Officer
    Mr. Jon R. Knight
    Vice President of US Commercial Operations
    Mr. Boris Gorelik
    Vice President of Business Development & Strategic Programs
    Mr. David Tsur
    Co-Founder & Independent Deputy Chairman of the Board
    Mr. Nir Livneh B.A., L.L.B.
    VP, General Counsel & Corporate Secretary
    Ms. Hanni Neheman
    Vice President of Marketing & Sales
    Ms. Liron Reshef
    Vice President of Human Resources
    Ms. Shavit Beladev
    Vice President of Kamada Plasma

    Important FAQs about investing in Kamada from India :

    What is Kamada share price today?

    Kamada share price today stands at $5.90, Open: $5.94 ; Previous Close: $5.85 ; High: $5.99 ; Low: $5.83 ; 52 Week High: $6.53 ; 52 Week Low: $4.74. The stock opens at $5.94, after a previous close of $5.85. The stock reached a daily high of $5.99 and a low of $5.83, with a 52-week high of $6.53 and a 52-week low of $4.74.

    Can Indians buy Kamada shares?

    Yes, Indians can invest in the Kamada (KMDA) from India.

    With INDmoney, you can buy Kamada at 0 brokerage. The step-by-step process is as follows:

    • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
    • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
    • Once funds are transferred successfully, you can buy Kamada at zero transaction cost.

    How can I buy Kamada shares from India?

    It is very easy to buy Kamada from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

    Can Fractional shares of Kamada be purchased?

    Yes, you can buy fractional shares of Kamada with INDmoney app.

    What are the documents required to start investing in Kamada stocks?

    To start investing in Kamada, You will need the following documents:

    • Proof of Identification (PAN, Aadhaar etc)
    • Proof of address (Aadhaar, Voter ID etc)

    These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

    What are today’s High and Low prices of Kamada

    Today’s highest price of Kamada (KMDA) is $5.99.

    Today’s lowest price of Kamada (KMDA) is $5.83.

    What is today's market capitalisation of Kamada

    Today's market capitalisation of Kamada KMDA is 350.6M

    What is the 52 Week High and Low Range of Kamada

    • 52 Week High

      $6.53

    • 52 Week Low

      $4.74

    What are the historical returns of Kamada?

    • 1 Month Returns

      0.85%

    • 3 Months Returns

      18.71%

    • 1 Year Returns

      -3.05%

    • 5 Years Returns

      -13.24%

    Who is the Chief Executive Officer (CEO) of Kamada

    Mr. Amir London is the current Chief Executive Officer (CEO) of Kamada.